BioCryst Pharmaceuticals, Inc. (BCRX)

Healthcare · Drug Manufacturers Specialty Generic · NASDAQ

BioCryst Pharmaceuticals, Inc. (BCRX) is a Healthcare company in the Drug Manufacturers Specialty Generic industry. It has a market capitalization of $2.40B, a trailing price-to-earnings ratio of 10.9 and a free-cash-flow yield of 16.8%. Over the most recent reported fiscal year, revenue grew 94.1%.

Market cap	$2.40B
Trailing P/E	10.9
FCF yield	16.8%
Revenue growth (YoY)	+94.1%
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Drug Manufacturers Specialty Generic

Explore live BCRX data on Nama Insights →

Recent Congressional trades

BioCryst Pharmaceuticals, Inc. trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
Gilbert Cisneros	House	Buy	$1,001 - $15,000	Dec 12, 2025
Josh Gottheimer	House	Buy	$1,001 - $15,000	Nov 7, 2023
Josh Gottheimer	House	Sell	$1,001 - $15,000	Oct 11, 2023